Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has The Prenatal Testing & Newborn Screening Market Size Shifted, And What Is the Outlook Through 2034?

In recent years, the market size for prenatal testing and newborn screening has seen rapid expansion. The predictions for growth place it at escalating from $6.24 billion in 2024 to $6.99 billion in 2025, indicating a compound annual growth rate (CAGR) of 12.0%. Elements contributing to this upward trend during the historical period include advancements in genetic testing, escalating maternal age, heightened awareness and education, and healthcare policies and regulations.

How Much Will the Prenatal Testing & Newborn Screening Market Be Worth in 2029?

Anticipated to experience swift expansion in the coming years, the market size of prenatal testing & newborn screening is predicted to mature to a value of $11.08 billion in 2029, boasting a compound annual growth rate (CAGR) of 12.2%. The acceleration in the forecast period is influenced by various factors such as genetic counseling, advancements in technology, point-of-care testing, along with telehealth and remote monitoring. During the forecast period, major trends are expected to encompass non-invasive prenatal testing (nipt), preimplantation genetic testing (pgt), telemedicine consultations, maternal blood testing, as well as hemoglobinopathies and sickle cell screening.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3350&type=smp

Which is the Largest Company in the Prenatal Testing & Newborn Screening Market?

Major companies operating in the prenatal testing & newborn screening market include PerkinElmer Inc., Laboratory Corporation of America Holdings (LabCorp), Natera Inc., Invitae Corporation, Centogene AG, Cradle Genomics Inc., Roche Diagnostics International AG, Quest Diagnostics Incorporated, Baebies Inc., Progenity Inc., Ravgen Inc., Strand Life Sciences Pvt. Ltd., Eurofins Scientific, Illumina Inc., Agilent Technologies Inc., Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories Inc., General Electric Company, Siemens Healthineers AG, BGI Group, QIAGEN N.V., Veracyte Inc., NIPD Genetics, Novacyt UK, Ariosa Diagnostics Inc., Verinata Health Inc., Counsyl a Myriad Company, GenPath Diagnostics, Sonic Healthcare Limited, Cepheid a Danaher Company, Guardant Health Inc., Genetron Health (Beijing) Co. Ltd.

What Are the Main Market Drivers in the Prenatal Testing & Newborn Screening Industry?

The considerable incidence of hereditary conditions in babies has fueled the expansion of the prenatal testing & newborn screening market. The World Health Organization reveals that genetic illnesses encompass ailments such as Thalassemia, Sickle Cell Anemia, Hemophilia, Cystic Fibrosis, Tay Sachs disease, Fragile X Syndrome, Huntington’s disease. Among these, sickle cell anemia impacts millions globally, with the disease especially prevalent among individuals whose forefathers hailed from regions like Africa, America, Cuba, Central America, Saudi Arabia, and India. For instance, a study performed at Rady Children’s Hospital by the U.S based Rady Children’s Institute for Genomic Medicine in February 2023 revealed that 41% of infant fatalities were associated with single-locus (Mendelian) genetic diseases. This significant incidence of genetic conditions in infants has amplified the demand, thus fostering the growth of the prenatal testing and newborn screening market.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3350&type=smp

How Is the Prenatal Testing & Newborn Screening Market Segments Structured?

The prenatal testing & newborn screening market covered in this report is segmented –

1) By Diagnostic Type: Non-Invasive, Invasive

2) By Technology: Screening Technology, Diagnostic Technology

3) By End user: Hospitals, Diagnostic centers

Subsegments:

1) By Non-Invasive: Blood Tests (Cell-Free DNA Testing), Ultrasound, Maternal Serum Screening

2) By Invasive: Amniocentesis, Chorionic Villus Sampling (CVS), Cordocentesis

What Strategic Trends Are Transforming the Prenatal Testing & Newborn Screening Market?

In the prenatal testing & newborn screening market, influential companies are placing a heavy emphasis on launching innovative programs that deploy rWGS (rapid Whole Genome Sequencing) technology. This advanced approach allows for swift and precise detection of genetic disorders in newborns, thus facilitating early prognosis and treatment to enhance health results. Unlike conventional gene testing techniques that only target specific genes or areas, rWGS examines the full genome of an individual, detecting genetic variations that could lead to diseases or disorders. For example, in June 2022, Rady Children’s Institute for Genomic Medicine, located in the US, introduced a ground-breaking program called BeginNGS. The program’s objective is to recognise and diagnose about 400 genetic disorders with existing treatment options before the disorders begin to show symptoms. BeginNGS is currently improving genomic sequencing procedures and plans to broaden its testing range to include about 1,000 disorders. The ultimate ambition is to make screening a standard procedure for 3.7 million newborns every year, across hospitals in the country.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/prenatal-testing-and-newborn-screening-global-market-report

Which Global Regions Offer the Highest Growth in the Prenatal Testing & Newborn Screening Market?

North America was the largest region in the prenatal testing & newborn screening market in 2023. Western Europe was the second largest region in the prenatal testing and newborn screening market. The regions covered in the prenatal testing & newborn screening market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3350

This Report Delivers Insight On:

1. How big is the prenatal testing & newborn screening market, and how is it changing globally?

2. Who are the major companies in the prenatal testing & newborn screening market, and how are they performing?

3. What are the key opportunities and risks in the prenatal testing & newborn screening market right now?

4. Which products or customer segments are growing the most in the prenatal testing & newborn screening market?

5. What factors are helping or slowing down the growth of the prenatal testing & newborn screening market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model